Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression profiling of melanoma brain metastases and matched extracranial metastases


ABSTRACT: An improved understanding of the molecular pathogenesis of brain metastases, one of the most common and devastating complications of advanced melanoma, may identify and prioritize rational therapeutic approaches for this disease. In particular, the identification of molecular differences between brain and extracranial metastases would support the need for the development of organ-specific therapeutic approaches. Hotspot mutations, copy number variations (CNV), global mRNA expression patterns, and protein expression and activation, quantitatively analyzed by molecular inversion probe arrays, microarrays and reverse phase protein array (RPPA) were evaluated in pairs of melanoma brain metastases and extracranial metastases from patients who had undergone surgical resection for both types of tumors. Seventy-two samples from 52 brain (except for patient 01, who had a spinal cord metastasis) and extracranial metastases of melanoma were analyzed. Available biological replicates (different parts of the same tumor) were included.

ORGANISM(S): Homo sapiens

SUBMITTER: Guo Chen 

PROVIDER: E-GEOD-50493 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target.

Chen Guo G   Chakravarti Nitin N   Aardalen Kimberly K   Lazar Alexander J AJ   Tetzlaff Michael T MT   Wubbenhorst Bradley B   Kim Sang-Bae SB   Kopetz Scott S   Ledoux Alicia A AA   Gopal Y N Vashisht YN   Pereira Cristiano Goncalves CG   Deng Wanleng W   Lee Ju-Seog JS   Nathanson Katherine L KL   Aldape Kenneth D KD   Prieto Victor G VG   Stuart Darrin D   Davies Michael A MA  

Clinical cancer research : an official journal of the American Association for Cancer Research 20140506 21


<h4>Purpose</h4>An improved understanding of the molecular pathogenesis of brain metastases, one of the most common and devastating complications of advanced melanoma, may identify and prioritize rational therapeutic approaches for this disease. In particular, the identification of molecular differences between brain and extracranial metastases would support the need for the development of organ-specific therapeutic approaches.<h4>Experimental design</h4>Hotspot mutations, copy number variations  ...[more]

Similar Datasets

2014-05-08 | GSE50493 | GEO
2014-05-08 | E-GEOD-50495 | biostudies-arrayexpress
2014-05-08 | GSE50495 | GEO
| PRJNA217773 | ENA
2014-05-08 | E-GEOD-50496 | biostudies-arrayexpress
2023-01-18 | GSE203152 | GEO
2022-07-06 | GSE200217 | GEO
2022-07-06 | GSE205033 | GEO
| PRJNA217776 | ENA
2022-07-06 | GSE200278 | GEO